Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden.
Giles SL et al. Clin Radiol. 2015 Mar 19. pii: S0009-9260(15)00074-4. doi: 10.1016/j.crad.2015.02.013. [Epub ahead of print].

The impact of circulating suppressor cells in multiple myeloma patients on clinical outcome of DLIs.
Franssen LE et al. Bone Marrow Transplant. 2015 Mar 23. doi: 10.1038/bmt.2015.48. [Epub ahead of print].

A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma.
Mai EK et al. Haematologica. 2015 Mar 20. pii: haematol.2015.124115. [Epub ahead of print].

Characterization of monoclonal gammopathy of undetermined significance by calorimetric analysis of blood serum proteome.
Barceló F et al. PLoS One. 2015 Mar 20;10(3):e0120316. doi: 10.1371/journal.pone.0120316. eCollection 2015.

The Use of MAGE C1 and Flow Cytometry to Determine the Malignant Cell Type in Multiple Myeloma.
Wienand K et al. PLoS One. 2015 Mar 20;10(3):e0120734. doi: 10.1371/journal.pone.0120734. eCollection 2015.

18F-FDG Dynamic PET/CT in Patients with Multiple Myeloma: Patterns of Tracer Uptake and Correlation With Bone Marrow Plasma Cell Infiltration Rate.
Sachpekidis C et al. Clin Nucl Med. 2015 Mar 17. [Epub ahead of print].

The Role of Positron Emission Tomography with 18F-Fluorodeoxyglucose Integrated with Computed Tomography in the Evaluation of Patients with Multiple Myeloma Undergoing Allogeneic Stem Cell Transplantation.
Patriarca F et al. Biol Blood Marrow Transplant. 2015 Mar 6. pii: S1083-8791(15)00173-1. doi: 10.1016/j.bbmt.2015.03.001. [Epub ahead of print].

The flow cytometry defined light chain cytoplasmic immunoglobulin Index and an associated twelve gene expression signature are independent prognostic factors in multiple myeloma.
Papanikolaou X et al. Leukemia. 2015 Mar 10. doi: 10.1038/leu.2015.65. [Epub ahead of print].

In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.
Philipp-Abbrederis K et al. EMBO Mol Med. 2015 Mar 3. pii: e201404698. doi: 10.15252/emmm.201404698. [Epub ahead of print].

Dual-Energy CT: Virtual Calcium Subtraction for Assessment of Bone Marrow Involvement of the Spine inMultiple Myeloma.
Thomas C et al. AJR Am J Roentgenol. 2015 Mar;204(3):W324-31. doi: 10.2214/AJR.14.12613.